Insight Molecular Diagnostics Inc. Common Stock

Medicare issued a favorable local coverage determination (LCD) for donor-derived cell-free DNA (dd-cfDNA) testing, expanding reimbursement for transplant organ monitoring. The policy increases surveillance testing frequencies across kidney and heart transplants compared to previous guidelines, supporting iMDx's commercial strategy for in-house te...